Core Viewpoint - Tenet Healthcare (THC) is positioned well to continue its trend of beating earnings estimates, with a strong history of surprises in recent quarters [1]. Earnings Performance - In the last reported quarter, Tenet achieved earnings of $2.93 per share, exceeding the Zacks Consensus Estimate of $2.33 per share, resulting in a surprise of 25.75% [2]. - For the previous quarter, Tenet's earnings were $2.31 per share against an expected $1.89 per share, delivering a surprise of 22.22% [2]. Earnings Estimates - Recent estimates for Tenet have been increasing, with a positive Earnings ESP (Expected Surprise Prediction) indicating potential for another earnings beat [3][6]. - The current Earnings ESP for Tenet is +0.10%, suggesting analysts are optimistic about its near-term earnings potential [6]. Predictive Metrics - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [4]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [5].

The most recent trading session ended with Tenet Healthcare (THC) standing at $130.21, reflecting a +1.09% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 0.16%. On the other hand, the Dow registered a gain of 0.25%, and the technology-centric Nasdaq decreased by 0.06%.Shares of the hospital operator witnessed a loss of 7.4% over the previous month, trailing the performance of the Medical sector with its loss of 5.77% and the S&P 500's loss of 2.8%.Market parti ...

If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!As the leader of the investing group Value In Corporate Events they provide members with opportunities to capitalize on IPOs, mergers & acquisitions, earnings reports and changes in corporate capi ...

Investors might want to bet on Tenet Healthcare (THC) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The powe ...

Tenet Healthcare (THC) closed at $129.64 in the latest trading session, marking a +0.14% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.73% for the day. Elsewhere, the Dow gained 0.16%, while the tech-heavy Nasdaq added 0.98%.The hospital operator's shares have seen a decrease of 9.87% over the last month, not keeping up with the Medical sector's loss of 3.8% and the S&P 500's gain of 0.34%.Market participants will be closely following the financial results of Ten ...

AI-Related Sectors in the US Economy - The US economy is experiencing a secular uptrend in sectors connected with AI [1] Tenet Healthcare Corporation (THC) - The article discusses reasons why Tenet Healthcare Corporation (THC) is worth considering, though specific reasons are not detailed in the provided content [1] Analyst's Position on THC - The analyst holds a beneficial long position in THC through stock ownership, options, or other derivatives [2] - The article reflects the analyst's personal opinions and is not influenced by compensation or business relationships with mentioned companies [2]

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Tenet Healthcare (THC) .Tenet currently has an average brokerage recommendation (ABR) of 1.32, ...

U.S. healthcare services company Tenet Healthcare Corporation (THC) declined 15.3% in the past month, underperforming the hospital industry and the S&P 500 Index. In comparison, its peers, HCA Healthcare, Inc. (HCA) and Select Medical Holdings Corporation (SEM) , have slipped 10.8% and 44.7%, respectively, during this time.The hospital industry is facing some challenges. Analysts expect that the new administration’s focus on cutting government spending and implementing changes could impact hospital profits ...

Core Viewpoint - Tenet Healthcare reported strong Q3 2024 earnings, with adjusted EPS of $2.93, exceeding estimates and more than doubling year-over-year, indicating robust operational performance despite recent stock underperformance [2][4]. Financial Performance - Adjusted net income reached $282 million, an increase of 84.3% year-over-year, surpassing management's expectations [4]. - Net operating revenues grew 1.1% year-over-year to $5.12 billion, exceeding management's guidance and consensus estimates [2][3]. - Adjusted EBITDA increased 14.5% year-over-year to $978 million, driven by improved same-hospital admissions and a favorable payer mix [5]. Segment Analysis - Hospital Operations and Services segment reported net operating revenues of $3.98 billion, down 3.4% year-over-year due to hospital divestitures, but same-hospital revenues improved by 6.1% [7]. - Ambulatory Care segment saw net operating revenues rise 21% year-over-year to $1.14 billion, attributed to facility buyouts and service line expansions [9]. Cost Management - Total operating costs decreased nearly 10% year-over-year to $4.1 billion, aided by lower salaries and higher net gains from facility sales [6]. Financial Position - As of September 30, 2024, Tenet had cash and cash equivalents of $4.1 billion, a significant increase from the previous year [12]. - Total assets rose to $29.4 billion, while long-term debt decreased by 14.2% to $12.8 billion [13]. Shareholder Returns - The company repurchased $124 million in common shares during Q3 [15]. Future Outlook - For Q4 2024, net operating revenues are projected between $5 billion and $5.2 billion, with adjusted EBITDA expected to range from $953 million to $1.05 billion [16]. - For the full year 2024, net operating revenues are forecasted between $20.6 billion and $20.8 billion, indicating a slight growth from 2023 [17]. Estimate Revisions - There has been an upward trend in earnings estimates, with a consensus shift of 7.47% in the past month [22][23]. Investment Sentiment - Tenet holds a Zacks Rank 1 (Strong Buy), reflecting positive investor sentiment and expectations for above-average returns in the coming months [25].

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors rely on traditional forms of ...